Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.9 pts less than Nifty Microcap 250 and 5.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Orchid Pharma Limited has submitted its financial results for the period ended March 31, 2025 to the stock exchange. This is a standard filing notification confirming that the company's quarterly/annual results have been disclosed via the exchange platform. The announcement itself does not include the detailed financial figures, auditor remarks, or comparative data. Investors should refer to the actual results document for revenue, profit, margin, and cash flow numbers. No specific financial metrics, auditor qualifications, or exceptional items are mentioned in this filing notification.
This is a procedural disclosure rather than a substantive announcement, so no immediate stock price catalyst is expected. Investors should review the actual results PDF for revenue trends, profitability, and any auditor flags before drawing conclusions.